ID: ALA3775061

Max Phase: Preclinical

Molecular Formula: C26H22FN9O

Molecular Weight: 495.52

Molecule Type: Small molecule

Representations

Canonical SMILES:  Cc1nc([C@@]2(c3cnn(C)c3)N[C@@H](c3nc(-c4ccc(F)cn4)c[nH]3)Cc3c2[nH]c2ccccc32)no1

Standard InChI:  InChI=1S/C26H22FN9O/c1-14-31-25(35-37-14)26(15-10-30-36(2)13-15)23-18(17-5-3-4-6-19(17)32-23)9-21(34-26)24-29-12-22(33-24)20-8-7-16(27)11-28-20/h3-8,10-13,21,32,34H,9H2,1-2H3,(H,29,33)/t21-,26+/m1/s1

Standard InChI Key:  MQOWSXSGMALBJL-RLWLMLJZSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 495.52

Molecular Weight (Monoisotopic): 495.1931

AlogP: 3.70

#Rotatable Bonds: 4

Polar Surface Area: 126.13

Molecular Species: NEUTRAL

HBA: 8

HBD: 3

#RO5 Violations: 0

HBA (Lipinski): 10

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 11.79

CX Basic pKa: 3.00

CX LogP: 3.17

CX LogD: 3.17

Aromatic Rings: 6

Heavy Atoms: 37

QED Weighted: 0.34

Np Likeness Score: -1.01

References

1. He S, Dobbelaar PH, Guo L, Ye Z, Liu J, Jian T, Truong Q, Shah SK, Du W, Qi H, Bakshi RK, Hong Q, Dellureficio JD, Sherer E, Pasternak A, Feng Z, Reibarkh M, Lin M, Samuel K, Reddy VB, Mitelman S, Tong SX, Chicchi GG, Tsao KL, Trusca D, Wu M, Shao Q, Trujillo ME, Fernandez G, Nelson D, Bunting P, Kerr J, Fitzgerald P, Morissette P, Volksdorf S, Eiermann GJ, Li C, Zhang BB, Howard AD, Zhou YP, Nargund RP, Hagmann WK..  (2016)  SAR exploration at the C-3 position of tetrahydro-β-carboline sstr3 antagonists.,  26  (6): [PMID:26898814] [10.1016/j.bmcl.2016.02.022]

Source

Source(1):

• Scientific Literature